https://massachusettshealthcarejournal.com/article/911523470-ispecimen-inc-announces-pricing-of-approximately-2-5-million-private-placement Massachusetts Healthcare Journal en PressRelease 2026-05-09T01:04:00+00:00 iSpecimen Inc. Announces Pricing of Approximately $2.5 Million Private Placement https://ml.globenewswire.com/media/MWMwZjE2YjEtYTE0Yy00NGY4LTljODctMDk0YTk0ZmI5N2E5LTUwMDEzMTIwMy0yMDI2LTA1LTA5LWVu/tiny/iSpecimen-Inc-.png https://massachusettshealthcarejournal.com/article/911523439-open-peer-review-exposes-upv-ethics-committee-s-dilemma-suppress-a-33-year-recognized-breakthrough-or-acknowledge-reviewer-s-ethical-violations-and Massachusetts Healthcare Journal en PressRelease 2026-05-09T00:24:14+00:00 Open Peer-Review Exposes UPV Ethics Committee’s Dilemma: Suppress a 33 Year Recognized Breakthrough or Acknowledge Reviewer’s Ethical Violations and Remit Final Judgement to the Known Dataset Test to Save Millions of Lives and Billions of Euros https://ml.globenewswire.com/media/40547009-5c5a-4f07-8621-de7e67578439/small/crosetto-foundation-logo-265-pixels-jpg.jpg https://massachusettshealthcarejournal.com/article/911507261-electrocore-to-present-at-the-ld-micro-invitational-xvi-conference-on-may-18-2026 Massachusetts Healthcare Journal en PressRelease 2026-05-09T00:00:00+00:00 electroCore to Present at the LD Micro Invitational XVI Conference on May 18, 2026 https://ml.globenewswire.com/media/b80ed5b6-a449-461c-9034-85386286b09d/small/ec-logo-2018-tm-cmyk-jpg.jpg https://massachusettshealthcarejournal.com/article/911490631-fda-expands-approval-of-vyvgart-and-vyvgart-hytrulo-to-all-adults-living-with-generalized-myasthenia-gravis Massachusetts Healthcare Journal en PressRelease 2026-05-08T22:27:12+00:00 FDA Expands Approval of VYVGART and VYVGART Hytrulo to All Adults Living with Generalized Myasthenia Gravis https://ml.globenewswire.com/media/YjJmNDYwNjUtMzcyOS00OGUxLTlhZGEtNDU1NmI4YjQxMTE1LTEwOTg0NjYtMjAyNi0wNS0wOC1lbg==/tiny/Muscular-Dystrophy-Association.png https://massachusettshealthcarejournal.com/article/911474186-argenx-announces-u-s-fda-approval-expanding-vyvgart-and-vyvgart-hytrulo-for-use-in-all-adult-patients-living-with-gmg Massachusetts Healthcare Journal en PressRelease 2026-05-08T21:20:00+00:00 argenx Announces U.S. FDA Approval Expanding VYVGART and VYVGART Hytrulo for Use in All Adult Patients Living with gMG https://ml-eu.globenewswire.com/media/be37b058-e737-46dc-b05a-c2240f4da489/small/argenx-logo-default-png.png https://massachusettshealthcarejournal.com/article/911474620-fda-grants-seventh-approval-under-the-national-priority-voucher-pilot-program Massachusetts Healthcare Journal en PressRelease 2026-05-08T21:00:59+00:00 FDA Grants Seventh Approval under the National Priority Voucher Pilot Program https://ml.globenewswire.com/media/M2FmNTlkNzctMTZlNi00NzQwLTk2OTctN2NmY2JiYzZhNTExLTUwMDE1NDE1NC0yMDI2LTA1LTA4LWVu/tiny/FDA.png https://massachusettshealthcarejournal.com/article/911474308-premier-health-announces-termination-of-forbearance-agreements-with-principal-lenders-and-the-continuance-of-its-strategic-review-process Massachusetts Healthcare Journal en PressRelease 2026-05-08T21:00:00+00:00 Premier Health Announces Termination of Forbearance Agreements With Principal Lenders and the Continuance of Its Strategic Review Process https://ml.globenewswire.com/media/b01bbc61-42f9-4000-9a0a-b1d6719f7396/small/pha-logo-png.png https://massachusettshealthcarejournal.com/article/911474191-fulcrum-therapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Massachusetts Healthcare Journal en PressRelease 2026-05-08T20:30:00+00:00 Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/3434fc83-4bcf-4d3c-ae26-23e5b1fd4252/small/fulcrum-logo-primary-full-color-rgb-large-png.png https://massachusettshealthcarejournal.com/article/911474276-mink-therapeutics-to-report-first-quarter-2026-financial-results-and-highlight-platform-progress-across-inkt-cell-therapy-programs Massachusetts Healthcare Journal en PressRelease 2026-05-08T20:30:00+00:00 MiNK Therapeutics to Report First Quarter 2026 Financial Results and Highlight Platform Progress Across iNKT Cell Therapy Programs https://ml.globenewswire.com/media/6aa8e960-515a-40d6-9894-39ca47f5c84e/small/mink-logo-loyal-blue-and-light-blue-png.png https://massachusettshealthcarejournal.com/article/911474434-azalea-therapeutics-announces-late-breaking-oral-presentation-at-asgct-annual-meeting-demonstrating-first-in-primate-in-vivo-trac-car-t-cell Massachusetts Healthcare Journal en PressRelease 2026-05-08T20:30:00+00:00 Azalea Therapeutics Announces Late-Breaking Oral Presentation at ASGCT Annual Meeting Demonstrating First-in-Primate In Vivo TRAC-CAR T Cell Engineering https://ml.globenewswire.com/media/074db8ed-c280-47d0-8c17-f1980e6b4ad3/small/azalea-therapeutics-logo-1200x353-png.png https://massachusettshealthcarejournal.com/article/911474524-fda-issues-guidance-to-improve-collection-of-pregnancy-safety-data-for-drugs-and-biologics Massachusetts Healthcare Journal en PressRelease 2026-05-08T20:24:44+00:00 FDA Issues Guidance to Improve Collection of Pregnancy Safety Data for Drugs and Biologics https://ml.globenewswire.com/media/MDU4NGIzYzgtOWZkYy00MmNkLWJkYTAtZjMxYzAwMmMxYTE0LTUwMDE1NDE1NC0yMDI2LTA1LTA4LWVu/tiny/FDA.png https://massachusettshealthcarejournal.com/article/911474239-vtv-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Massachusetts Healthcare Journal en PressRelease 2026-05-08T20:15:00+00:00 vTv Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/27198d2d-fdd5-4f74-8f54-7a9e5876e06d/small/vtv-therapeutics-color-jpg.jpg https://massachusettshealthcarejournal.com/article/911474168-invitation-to-attend-the-annual-and-the-extraordinary-shareholders-meetings-of-the-company-to-be-held-on-june-10-2026 Massachusetts Healthcare Journal en PressRelease 2026-05-08T20:05:00+00:00 Invitation to attend the annual and the extraordinary shareholders’ meetings of the Company to be held on June 10, 2026 https://ml-eu.globenewswire.com/media/a71f8653-a2aa-46a0-ad48-7eb6b9091673/small/logo-nyxoah-rgb-png.png https://massachusettshealthcarejournal.com/article/911474172-invitation-assister-l-assembl-e-g-n-rale-annuelle-et-extraordinaire-des-actionnaires-de-la-soci-t-qui-se-tiendra-le-10-juin-2026 Massachusetts Healthcare Journal en PressRelease 2026-05-08T20:05:00+00:00 Invitation à assister à l'assemblée générale annuelle et extraordinaire des actionnaires de la Société qui se tiendra le 10 juin 2026 https://ml-eu.globenewswire.com/media/a71f8653-a2aa-46a0-ad48-7eb6b9091673/small/ https://massachusettshealthcarejournal.com/article/911474196-vera-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Massachusetts Healthcare Journal en PressRelease 2026-05-08T20:05:00+00:00 Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/25b71017-1f55-4adb-9d6a-17c2ba55b36e/small/cropped-logo-digital-png.png https://massachusettshealthcarejournal.com/article/911474206-femasys-announces-financial-results-for-quarter-ended-march-31-2026-and-provides-corporate-update Massachusetts Healthcare Journal en PressRelease 2026-05-08T20:05:00+00:00 Femasys Announces Financial Results for Quarter Ended March 31, 2026 and Provides Corporate Update https://ml.globenewswire.com/media/c668c3db-ff7f-4eb5-b51a-b8db25e838b4/small/femasys-logo-2-jpg.jpg https://massachusettshealthcarejournal.com/article/911474223-entera-announces-first-quarter-2026-financial-results-and-updates-across-its-oral-peptide-programs Massachusetts Healthcare Journal en PressRelease 2026-05-08T20:05:00+00:00 Entera Announces First Quarter 2026 Financial Results and Updates Across its Oral Peptide Programs https://ml.globenewswire.com/media/9b4ae2bf-733d-4180-b48c-d0fa3f26c81a/small/logo-png.png https://massachusettshealthcarejournal.com/article/911474252-tenax-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Massachusetts Healthcare Journal en PressRelease 2026-05-08T20:05:00+00:00 Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/d8c1d3b1-51a5-4835-a9e8-6d5bce14917e/small/tenax-logo-rgb-color-jpg.jpg https://massachusettshealthcarejournal.com/article/911474273-ocular-therapeutix-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Massachusetts Healthcare Journal en PressRelease 2026-05-08T20:05:00+00:00 Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/20ee0f50-7288-4f81-8546-f2ad2050ddbf/small/ocul-logo-jpg.jpg https://massachusettshealthcarejournal.com/article/911474329-tomi-environmental-solutions-inc-reports-first-quarter-2026-financial-results-and-announces-transformative-letter-of-intent-to-merge-with-carbonium Massachusetts Healthcare Journal en PressRelease 2026-05-08T20:05:00+00:00 TOMI Environmental Solutions, Inc. Reports First Quarter 2026 Financial Results and Announces Transformative Letter of Intent to Merge with Carbonium Core, Inc. https://ml.globenewswire.com/media/f8c7c513-0121-4507-84b7-3680626d9cf3/small/tomi-jpg.jpg https://massachusettshealthcarejournal.com/article/911474339-longeveron-announces-constructive-type-c-meeting-with-u-s-fda-ahead-of-data-readout-for-elpis-ii-phase-2b-clinical-trial-evaluating-treatment-for Massachusetts Healthcare Journal en PressRelease 2026-05-08T20:05:00+00:00 Longeveron Announces Constructive Type C Meeting with U.S. FDA Ahead of Data Readout for ELPIS II Phase 2b Clinical Trial Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS) https://ml.globenewswire.com/media/a6d6e61c-2a7d-4b22-954b-04b9841fbc38/small/longeveron-logo-jpg.jpg https://massachusettshealthcarejournal.com/article/911474376-james-cacioppo-files-updated-early-warning-report Massachusetts Healthcare Journal en PressRelease 2026-05-08T20:05:00+00:00 James Cacioppo Files Updated Early Warning Report https://ml.globenewswire.com/media/e65f15fd-322c-4847-83c5-ceafe27f97d5/small/jushi-png.png https://massachusettshealthcarejournal.com/article/911474203-bridgebio-pharma-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Massachusetts Healthcare Journal en PressRelease 2026-05-08T20:01:00+00:00 BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png https://massachusettshealthcarejournal.com/article/911474216-arcutis-biotherapeutics-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Massachusetts Healthcare Journal en PressRelease 2026-05-08T20:00:00+00:00 Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/1b166f47-afb1-44f1-91be-2d73e97c0ec3/small/arcutis-logo-png.png https://massachusettshealthcarejournal.com/article/911474472-biofrontera-inc-to-report-first-quarter-2026-financial-results-and-host-a-conference-call-on-may-14-2026 Massachusetts Healthcare Journal en PressRelease 2026-05-08T20:00:00+00:00 Biofrontera Inc. to Report First Quarter 2026 Financial Results and Host a Conference Call on May 14, 2026 https://ml.globenewswire.com/media/4af5197e-340e-4307-892b-382a1d29ae45/small/logo-png.png https://massachusettshealthcarejournal.com/article/911457438-shiny-smile-veneers-under-investigation-evaluating-the-dentist-designed-custom-fit-snap-on-top-bottom-veneer-claims Massachusetts Healthcare Journal en PressRelease 2026-05-08T19:51:07+00:00 Shiny Smile Veneers Under Investigation: Evaluating the Dentist-Designed Custom Fit Snap-On Top & Bottom Veneer Claims https://zingfast.com/wp-content/uploads/2026/05/Shiny-Smile-Veneers.jpg https://massachusettshealthcarejournal.com/article/911457434-fitness-online-named-best-fitness-mobile-app-in-10th-annual-medtech-breakthrough-awards-program Massachusetts Healthcare Journal en PressRelease 2026-05-08T19:29:53+00:00 Fitness Online Named “Best Fitness Mobile App” in 10th Annual MedTech Breakthrough Awards Program https://ml.globenewswire.com/media/27a7520b-9ae6-414c-ae9d-5267dc364671/small/medtech-png.png https://massachusettshealthcarejournal.com/article/911457397-major-shareholder-announcement Massachusetts Healthcare Journal en PressRelease 2026-05-08T19:05:12+00:00 Major Shareholder Announcement https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg https://massachusettshealthcarejournal.com/article/911457422-her-bodhi-claims-evaluated-meno-hormonal-support-for-women-by-herbodhi-under-investigation Massachusetts Healthcare Journal en PressRelease 2026-05-08T18:46:22+00:00 Her Bodhi Claims Evaluated: Meno & Hormonal Support for Women by HerBodhi Under Investigation https://zingfast.com/wp-content/uploads/2026/05/Her-Bodhi.jpg https://massachusettshealthcarejournal.com/article/911439926-more-life-summit-2026-brings-the-world-s-leading-voices-in-longevity-performance-faith-purpose-to-miami-this-october Massachusetts Healthcare Journal en PressRelease 2026-05-08T17:12:36+00:00 More Life Summit 2026 Brings the World's Leading Voices in Longevity, Performance, Faith & Purpose to Miami this October https://ml.globenewswire.com/media/6f384cad-1646-4d58-bf63-e08230833288/medium/more-life-summit-2026-miami-fl.png https://massachusettshealthcarejournal.com/article/911404232-erdem-health-group-enters-t-rkiye-s-turquality-program Massachusetts Healthcare Journal en PressRelease 2026-05-08T15:00:00+00:00 Erdem Health Group Enters Türkiye’s TURQUALITY Program https://ml-eu.globenewswire.com/media/6d9ebfda-b492-4767-8803-0c83321cdd01/medium/cakmak-erdem-hospital.jpg https://massachusettshealthcarejournal.com/article/911404291-cytokinetics-announces-closing-of-public-offering-of-common-stock-and-full-exercise-of-the-underwriters-option-to-purchase-additional-shares-for Massachusetts Healthcare Journal en PressRelease 2026-05-08T14:51:36+00:00 Cytokinetics Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $805 Million https://ml.globenewswire.com/media/52e2be9f-e9e3-43af-a747-123fdcac4253/small/cytokinetics-png.png https://massachusettshealthcarejournal.com/article/911386290-inspire-named-best-patient-experience-platform-in-10th-annual-medtech-breakthrough-awards-program Massachusetts Healthcare Journal en PressRelease 2026-05-08T14:10:00+00:00 Inspire Named “Best Patient Experience Platform” in 10th Annual MedTech Breakthrough Awards Program https://ml.globenewswire.com/media/OWVkODQ2MTktZDk0YS00M2Q0LWJlYmItYTIyYTRjMTgxZDUzLTUwMDEyOTE4NC0yMDI2LTA1LTA4LWVu/tiny/Inspire.png https://massachusettshealthcarejournal.com/article/911386518-ai-technology-transforms-cannabis-industry-as-leading-operators-drive-adoption-to-enhance-yields-and-compliance Massachusetts Healthcare Journal en PressRelease 2026-05-08T13:52:16+00:00 AI Technology Transforms Cannabis Industry as Leading Operators Drive Adoption to Enhance Yields and Compliance https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://massachusettshealthcarejournal.com/article/911386301-merit-medical-to-participate-in-the-bank-of-america-healthcare-conference Massachusetts Healthcare Journal en PressRelease 2026-05-08T13:25:00+00:00 Merit Medical to Participate in the Bank of America Healthcare Conference https://ml.globenewswire.com/media/19958d8f-47a4-44f3-a780-247335a68768/small/merit-medical-systems-inc-logo.jpg https://massachusettshealthcarejournal.com/article/911386310-envue-medical-adds-to-intellectual-property-portfolio-by-securing-uspto-notice-of-allowance-for-ultrasound-enhanced-cannabinoid-drug-delivery Massachusetts Healthcare Journal en PressRelease 2026-05-08T13:15:00+00:00 ENvue Medical Adds to Intellectual Property Portfolio by Securing USPTO Notice of Allowance for Ultrasound-Enhanced Cannabinoid Drug Delivery Technology https://ml.globenewswire.com/media/e0a97028-a7c3-4dd6-a13f-a55e43617883/small/logo-small-722-jpg.jpg https://massachusettshealthcarejournal.com/article/911370850-alpha-tau-to-host-conference-call-to-discuss-interim-results-from-first-three-patients-treated-for-recurrent-glioblastoma Massachusetts Healthcare Journal en PressRelease 2026-05-08T13:10:00+00:00 Alpha Tau to Host Conference Call to Discuss Interim Results from First Three Patients Treated for Recurrent Glioblastoma https://ml.globenewswire.com/media/a9de6f03-a487-4934-98e9-d25cdb4c8bed/small/atm-logo-jpg.jpg https://massachusettshealthcarejournal.com/article/911370178-philips-shareholders-approve-all-proposals-at-the-agm-2026 Massachusetts Healthcare Journal en PressRelease 2026-05-08T13:01:04+00:00 Philips shareholders approve all proposals at the AGM 2026 https://ml-eu.globenewswire.com/media/e5826782-01bc-45e7-b448-9ca1eae0125e/small/philips-logo-logotype-emblem-700x128-png.png https://massachusettshealthcarejournal.com/article/911370587-bioage-labs-reports-first-quarter-2026-financial-results-and-provides-business-updates Massachusetts Healthcare Journal en PressRelease 2026-05-08T13:00:00+00:00 BioAge Labs Reports First Quarter 2026 Financial Results and Provides Business Updates https://ml.globenewswire.com/media/d6df9eb5-87f7-4e2e-b503-8a7d8651428e/small/bioage-dark-logo-white-bg-500x500-png.png https://massachusettshealthcarejournal.com/article/911370826-alpha-tau-completes-patient-enrollment-in-its-u-s-pivotal-skin-cancer-study-advancing-towards-goal-of-fda-approval-of-alpha-dart-to-treat-recurrent Massachusetts Healthcare Journal en PressRelease 2026-05-08T13:00:00+00:00 Alpha Tau Completes Patient Enrollment in its U.S. Pivotal Skin Cancer Study, Advancing Towards Goal of FDA Approval of Alpha DaRT® to Treat Recurrent Cutaneous Squamous Cell Carcinoma https://ml.globenewswire.com/media/a9de6f03-a487-4934-98e9-d25cdb4c8bed/small/atm-logo-jpg.jpg https://massachusettshealthcarejournal.com/article/911370911-j-star-holding-signs-mou-with-white-group-to-advance-financing-for-texas-solid-state-battery-facility Massachusetts Healthcare Journal en PressRelease 2026-05-08T13:00:00+00:00 J-Star Holding Signs MOU with White Group to Advance Financing for Texas Solid-State Battery Facility https://ml.globenewswire.com/media/1a4c6faf-93be-4d28-a35f-1df9c4f0404e/small/j-star-logo-blue-transparent-png.png https://massachusettshealthcarejournal.com/article/911370159-allarity-therapeutics-ceo-to-present-at-precision-medicine-forum-europe-2026-in-stockholm Massachusetts Healthcare Journal en PressRelease 2026-05-08T12:45:00+00:00 Allarity Therapeutics CEO to Present at Precision Medicine Forum Europe 2026 in Stockholm https://ml-eu.globenewswire.com/media/fd1e4c64-f0cf-40e0-a0c9-0be0d6dce544/small/allarity-full-color-rgb-2023jun07-png.png https://massachusettshealthcarejournal.com/article/911370672-moleculin-biotech-secures-strategic-additional-patent-strengthening-global-positioning-of-annamycin Massachusetts Healthcare Journal en PressRelease 2026-05-08T12:45:00+00:00 Moleculin Biotech Secures Strategic Additional Patent, Strengthening Global Positioning of Annamycin https://ml.globenewswire.com/media/7fa09722-2ef8-49fc-bc24-6b150093f8ba/small/mbrx-logo-png.png https://massachusettshealthcarejournal.com/article/911371106-aim-immunotech-inc-announces-exercise-of-warrants-for-approx-4-2-million-in-gross-proceeds Massachusetts Healthcare Journal en PressRelease 2026-05-08T12:40:00+00:00 AIM ImmunoTech, Inc. Announces Exercise of Warrants for Approx. $4.2 Million in Gross Proceeds https://ml.globenewswire.com/media/8e85b83b-047f-4f99-9c51-1aa232ffe9bb/small/aimlogo-jpg.jpg https://massachusettshealthcarejournal.com/article/911370349-aclaris-therapeutics-to-participate-in-the-2026-bank-of-america-healthcare-conference Massachusetts Healthcare Journal en PressRelease 2026-05-08T12:30:00+00:00 Aclaris Therapeutics to Participate in the 2026 Bank of America Healthcare Conference https://ml.globenewswire.com/media/de2bcb21-de59-4226-bc8b-b1b747461f51/small/aclaris-logo-clr-jpg.jpg https://massachusettshealthcarejournal.com/article/911370612-prenetics-to-report-q1-2026-financial-results-on-may-14-2026-and-host-earnings-conference-call Massachusetts Healthcare Journal en PressRelease 2026-05-08T12:30:00+00:00 Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference Call https://ml.globenewswire.com/media/106dbe1a-a6e1-49d9-97a2-c5609258bdc7/small/pre-logo-2026-png.png https://massachusettshealthcarejournal.com/article/911370712-cg-oncology-reports-first-quarter-2026-financial-results-and-provides-business-updates Massachusetts Healthcare Journal en PressRelease 2026-05-08T12:30:00+00:00 CG Oncology Reports First Quarter 2026 Financial Results and Provides Business Updates https://ml.globenewswire.com/media/9e1cbdea-928e-4ea4-b4cd-33cdc36c6b2f/small/cgoncology-cover-jpg.jpg https://massachusettshealthcarejournal.com/article/911370964-inflarx-announces-closing-of-150-million-underwritten-offering-of-ordinary-shares Massachusetts Healthcare Journal en PressRelease 2026-05-08T12:15:00+00:00 InflaRx Announces Closing of $150 Million Underwritten Offering of Ordinary Shares https://ml.globenewswire.com/media/e017df5c-9a9b-4f4f-9a94-6c2eeb0400bc/small/inflarx-logo-png.png https://massachusettshealthcarejournal.com/article/911370316-mimedx-announces-launch-of-g4derm-plus Massachusetts Healthcare Journal en PressRelease 2026-05-08T12:00:00+00:00 MIMEDX Announces Launch of G4Derm® Plus https://ml.globenewswire.com/media/2a60ab36-4917-479c-b53a-4f2113ca347d/small/mimedx-png.png https://massachusettshealthcarejournal.com/article/911370604-humacyte-to-announce-2026-first-quarter-financial-results-and-provide-business-update-on-may-13-2026 Massachusetts Healthcare Journal en PressRelease 2026-05-08T12:00:00+00:00 Humacyte To Announce 2026 First Quarter Financial Results and Provide Business Update on May 13, 2026 https://ml.globenewswire.com/media/e81aff26-ead8-404d-aebb-159b45c3e7b1/small/huma-logo-png.png https://massachusettshealthcarejournal.com/article/911370607-alx-oncology-reports-first-quarter-2026-financial-results-and-provides-corporate-update Massachusetts Healthcare Journal en PressRelease 2026-05-08T12:00:00+00:00 ALX Oncology Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/0a1b4459-3df3-4c9f-ba29-ace8d7ad1b9a/small/alx-01-stacked-white-png.png https://massachusettshealthcarejournal.com/article/911370619-integra-lifesciences-to-present-at-the-bofa-securities-2026-health-care-conference Massachusetts Healthcare Journal en PressRelease 2026-05-08T12:00:00+00:00 Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference https://ml.globenewswire.com/media/80d27f1a-2d8e-44f2-92e9-57e14db38652/small/integra-promotional-logos-integra-logo-full-color-process-1.png https://massachusettshealthcarejournal.com/article/911370636-pacira-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Massachusetts Healthcare Journal en PressRelease 2026-05-08T12:00:00+00:00 Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/3e502c92-e576-46b6-b602-a177ab0f5044/small/pacira-biosciences-tm-logo-rgb-v2025-300dpi-adj-png.png https://massachusettshealthcarejournal.com/article/911370805-biocardia-and-fda-align-on-helix-transendocardial-delivery-catheter-clearance-pathways Massachusetts Healthcare Journal en PressRelease 2026-05-08T12:00:00+00:00 BioCardia and FDA Align on Helix Transendocardial Delivery Catheter Clearance Pathways https://ml.globenewswire.com/media/4641bb53-4913-4654-a337-79383a5c7ab9/small/biocardia-final-logo-2016-jpeg-jpg.jpg https://massachusettshealthcarejournal.com/article/911370907-alamar-biosciences-reports-first-quarter-2026-financial-results Massachusetts Healthcare Journal en PressRelease 2026-05-08T12:00:00+00:00 Alamar Biosciences Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/9394cf1d-76c7-4cf9-8ed3-cafcc57c9a84/small/alamardroplogo-4c-png.png https://massachusettshealthcarejournal.com/article/911355251-plus-therapeutics-announces-oral-presentation-highlighting-reyobiq-clinical-and-translational-data-demonstrating-favorable-safety-survival-and Massachusetts Healthcare Journal en PressRelease 2026-05-08T11:30:00+00:00 Plus Therapeutics Announces Oral Presentation Highlighting REYOBIQ™ Clinical and Translational Data Demonstrating Favorable Safety, Survival, and Emerging Immunomodulation in Leptomeningeal Metastases https://ml.globenewswire.com/media/92d7aa70-e37d-4870-bccf-d83b68ba5612/small/plus-logo-png.png https://massachusettshealthcarejournal.com/article/911355675-avicanna-announces-results-of-annual-general-and-special-meeting Massachusetts Healthcare Journal en PressRelease 2026-05-08T11:30:00+00:00 Avicanna Announces Results of Annual General and Special Meeting https://ml.globenewswire.com/media/c9abc2f4-efdc-40f6-921d-a5da048eda46/small/avicanna-logo-colour-withtm-01-png.png https://massachusettshealthcarejournal.com/article/911355689-traws-pharma-to-advance-potential-clinical-candidates-for-the-treatment-of-hantavirus-infections Massachusetts Healthcare Journal en PressRelease 2026-05-08T11:30:00+00:00 Traws Pharma to Advance Potential Clinical Candidates for the Treatment of Hantavirus Infections https://ml.globenewswire.com/media/1eb1780a-724e-4555-ab4d-455e27d18544/small/traws-pharma-blue-png.png https://massachusettshealthcarejournal.com/article/911355706-spectral-medical-announces-first-quarter-2026-financial-results-and-provides-corporate-update Massachusetts Healthcare Journal en PressRelease 2026-05-08T11:30:00+00:00 Spectral Medical Announces First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/9516c02b-7f3b-41c0-bac1-a037af9a3240/small/new-spectral-logo-rgb-jpg.jpg https://massachusettshealthcarejournal.com/article/911355617-treace-medical-concepts-reports-first-quarter-2026-financial-results Massachusetts Healthcare Journal en PressRelease 2026-05-08T11:05:00+00:00 Treace Medical Concepts Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/e6af4ccc-19b1-4fe0-948f-436f2b9d2ea5/small/treace-color-jpg.jpg https://massachusettshealthcarejournal.com/article/911355088-oxb-to-exhibit-and-present-at-the-30th-annual-meeting-of-the-american-society-of-cell-and-gene-therapy-asgct Massachusetts Healthcare Journal en PressRelease 2026-05-08T11:00:00+00:00 OXB to exhibit and present at the 30th Annual Meeting of the American Society of Cell and Gene Therapy (ASGCT) https://ml-eu.globenewswire.com/media/3e905c0a-b28c-4981-ac57-745647779ad9/small/oxb-new-logo-png.png https://massachusettshealthcarejournal.com/article/911355200-le-consortium-international-de-recherche-sur-le-cancer-de-l-ovaire-annonce-une-nouvelle-bourse-pour-des-recherches-propuls-es-par-l-ia-visant-faire Massachusetts Healthcare Journal en PressRelease 2026-05-08T11:00:00+00:00 Le Consortium international de recherche sur le cancer de l’ovaire annonce une nouvelle bourse pour des recherches propulsées par l’IA, visant à faire progresser les découvertes fondées sur les données https://ml.globenewswire.com/media/6d2e71b6-7ea9-4218-b59d-c718b24d7382/small/occ-logo-fr-clr-rgb-png.png https://massachusettshealthcarejournal.com/article/911355203-global-ovarian-cancer-research-consortium-announces-next-ai-accelerator-grant-to-advance-data-driven-discovery Massachusetts Healthcare Journal en PressRelease 2026-05-08T11:00:00+00:00 Global Ovarian Cancer Research Consortium Announces Next AI Accelerator Grant to Advance Data-Driven Discovery https://ml.globenewswire.com/media/de07035a-bbf6-48bd-b4ea-ec41c0d06771/small/occ-logo-en-clr-rgb-1-png.png https://massachusettshealthcarejournal.com/article/911355434-lensar-reports-first-quarter-2026-results-and-provides-business-update Massachusetts Healthcare Journal en PressRelease 2026-05-08T11:00:00+00:00 LENSAR® Reports First Quarter 2026 Results and Provides Business Update https://ml.globenewswire.com/media/4768eddf-0f87-4479-87f6-6b81f8ff392a/small/lensar-4color-jpg.jpg https://massachusettshealthcarejournal.com/article/911355605-boundless-bio-reports-first-quarter-2026-financial-results-and-business-highlights Massachusetts Healthcare Journal en PressRelease 2026-05-08T11:00:00+00:00 Boundless Bio Reports First Quarter 2026 Financial Results and Business Highlights https://ml.globenewswire.com/media/3b8ff619-e7af-4c58-a7f2-de0c4019068d/small/boundlessbiologo-jpg.jpg https://massachusettshealthcarejournal.com/article/911355613-regeneron-named-to-dow-jones-best-in-class-world-index-for-global-responsibility-leadership-for-seven-consecutive-years Massachusetts Healthcare Journal en PressRelease 2026-05-08T11:00:00+00:00 Regeneron Named to Dow Jones Best-in-Class World Index for Global Responsibility Leadership for Seven Consecutive Years https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg https://massachusettshealthcarejournal.com/article/911355644-hyperion-defi-announces-closing-of-public-offering-of-common-stock Massachusetts Healthcare Journal en PressRelease 2026-05-08T11:00:00+00:00 Hyperion DeFi Announces Closing of Public Offering of Common Stock https://ml.globenewswire.com/media/2b21f207-e46f-4ad9-a6be-573e0bdc6c4c/small/hyperion-defi-single-logo-jpg.jpg https://massachusettshealthcarejournal.com/article/911355660-tvardi-therapeutics-announces-first-quarter-2026-results-and-provides-business-update Massachusetts Healthcare Journal en PressRelease 2026-05-08T11:00:00+00:00 Tvardi Therapeutics Announces First Quarter 2026 Results and Provides Business Update https://ml.globenewswire.com/media/65859e40-e7db-474e-b604-78033b160f6b/small/tvardi-therapeutics-logo-1200-jpg.jpg https://massachusettshealthcarejournal.com/article/911355697-maplight-therapeutics-to-participate-in-upcoming-investor-conferences Massachusetts Healthcare Journal en PressRelease 2026-05-08T11:00:00+00:00 MapLight Therapeutics to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/173b471e-5a67-4f12-84f2-06f4980ebd76/small/maplight-logo-horizontal-web-color-png.png https://massachusettshealthcarejournal.com/article/911355719-artiva-biotherapeutics-announces-pricing-of-300-million-underwritten-offering-of-common-stock-and-pre-funded-warrants Massachusetts Healthcare Journal en PressRelease 2026-05-08T10:52:31+00:00 Artiva Biotherapeutics Announces Pricing of $300 Million Underwritten Offering of Common Stock and Pre-Funded Warrants https://ml.globenewswire.com/media/0392544b-ecff-4590-9eed-59c934e1ba4d/small/artiva-biotherapeutics-logo-jpg.jpg https://massachusettshealthcarejournal.com/article/911355628-ani-pharmaceuticals-reports-first-quarter-2026-financial-results-and-raises-2026-financial-guidance Massachusetts Healthcare Journal en PressRelease 2026-05-08T10:50:00+00:00 ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance https://ml.globenewswire.com/media/24d1d851-9075-4d6e-b22c-0c23a5ef0b36/small/ani-logo-png.png https://massachusettshealthcarejournal.com/article/911340646-artiva-biotherapeutics-reports-first-quarter-2026-financial-results-and-recent-business-highlights Massachusetts Healthcare Journal en PressRelease 2026-05-08T10:31:00+00:00 Artiva Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights https://ml.globenewswire.com/media/0392544b-ecff-4590-9eed-59c934e1ba4d/small/artiva-biotherapeutics-logo-jpg.jpg https://massachusettshealthcarejournal.com/article/911340634-knight-therapeutics-announces-regulatory-approval-of-tavalisse-in-brazil Massachusetts Healthcare Journal en PressRelease 2026-05-08T10:30:00+00:00 Knight Therapeutics Announces Regulatory Approval of TAVALISSE® in Brazil https://ml.globenewswire.com/media/e9457092-692d-4bfd-b361-9799ee8d73cd/small/logo-knight-256x256px-jpg.jpg https://massachusettshealthcarejournal.com/article/911340639-th-rapeutique-knight-annonce-l-approbation-r-glementaire-de-tavalisse-au-br-sil Massachusetts Healthcare Journal en PressRelease 2026-05-08T10:30:00+00:00 Thérapeutique Knight annonce l’approbation réglementaire de TAVALISSE® au Brésil https://ml.globenewswire.com/media/e9457092-692d-4bfd-b361-9799ee8d73cd/small/logo-knight-256x256px-jpg.jpg https://massachusettshealthcarejournal.com/article/911340666-artiva-announces-positive-initial-clinical-data-with-allonk-across-multiple-autoimmune-diseases-and-fda-alignment-to-initiate-phase-3-registrational Massachusetts Healthcare Journal en PressRelease 2026-05-08T10:30:00+00:00 Artiva Announces Positive Initial Clinical Data with AlloNK® Across Multiple Autoimmune Diseases and FDA Alignment to Initiate Phase 3 Registrational Trial in Rheumatoid Arthritis in 2026 https://ml.globenewswire.com/media/0392544b-ecff-4590-9eed-59c934e1ba4d/small/artiva-biotherapeutics-logo-jpg.jpg https://massachusettshealthcarejournal.com/article/911340599-nxera-files-patent-infringement-action-in-relation-to-its-minig-platform-technology Massachusetts Healthcare Journal en PressRelease 2026-05-08T10:26:31+00:00 Nxera Files Patent Infringement Action in Relation to its miniG Platform Technology https://ml-eu.globenewswire.com/media/5cc74d52-c86f-4e21-8684-3496281fee15/small/nxera-master-logo-rgb-black-1-png.png https://massachusettshealthcarejournal.com/article/911340746-angel-expands-u-s-water-purification-lineup-with-new-whole-house-water-filtration-systems Massachusetts Healthcare Journal en PressRelease 2026-05-08T10:20:18+00:00 ANGEL Expands U.S. Water Purification Lineup with New Whole House Water Filtration Systems https://ml.globenewswire.com/media/c9f92ea2-5454-4357-8a0b-3955c66106f3/medium/image-1.jpeg https://massachusettshealthcarejournal.com/article/911340682-profusa-receives-favorable-nasdaq-listing-determination Massachusetts Healthcare Journal en PressRelease 2026-05-08T10:00:00+00:00 Profusa Receives Favorable Nasdaq Listing Determination https://ml.globenewswire.com/media/a8137a61-b858-48da-9e47-1f1bf8f6ddba/small/profusa-logo-jpg.jpg https://massachusettshealthcarejournal.com/article/911340704-pharvaris-announces-pricing-of-115-million-underwritten-offering-of-ordinary-shares Massachusetts Healthcare Journal en PressRelease 2026-05-08T10:00:00+00:00 Pharvaris Announces Pricing of $115 Million Underwritten Offering of Ordinary Shares https://ml.globenewswire.com/media/4f758956-d75c-4020-9df0-b14d01115a1b/small/pharvaris-logo-png.png https://massachusettshealthcarejournal.com/article/911102923-social-isolation-poses-health-risk-comparable-to-smoking-worcester-library-program-offers-a-powerful-local-solution Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:49:45+00:00 Social Isolation Poses Health Risk Comparable to Smoking—Worcester Library Program Offers a Powerful Local Solution https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24850252-senior-group-reading-together-1890x1534.png https://massachusettshealthcarejournal.com/article/911172226-boston-gynecomastia-specialists-establishes-itself-as-the-region-s-premier-dedicated-male-breast-reduction-practice Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:19:54+00:00 Boston Gynecomastia Specialists establishes itself as the region’s premier dedicated Male Breast Reduction practice https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24850561-chestsculpt-transformation-960x1004.png https://massachusettshealthcarejournal.com/article/911307449-update-on-fda-priority-review-of-leqembi-iqlik-lecanemab-irmb-subcutaneous-injection-as-a-starting-dose-for-early-alzheimer-s-disease Massachusetts Healthcare Journal en PressRelease 2026-05-08T06:30:00+00:00 Update on FDA Priority Review of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection as a Starting Dose for Early Alzheimer’s Disease https://ml.globenewswire.com/media/80f9c524-3da2-4583-a763-0dad931fa182/small/biogen-logo-standard-rgb-r-jpg.jpg https://massachusettshealthcarejournal.com/article/911110356-zacademy-launches-human-in-the-healthcare-loop-podcast-to-show-the-real-people-leveraging-the-system-behind-the-scenes Massachusetts Healthcare Journal en PressRelease 2026-05-07T15:14:57+00:00 zAcademy Launches Human in the Healthcare Loop Podcast to Show the Real People Leveraging the System Behind the Scenes https://massachusettshealthcarejournal.com/article/910893920-pioneer-study-seniors-paid-more-for-key-drugs-despite-federal-price-controls Massachusetts Healthcare Journal en PressRelease 2026-05-07T15:00:00+00:00 Pioneer Study: Seniors Paid More for Key Drugs Despite Federal Price Controls https://massachusettshealthcarejournal.com/article/911268606-lifestance-health-group-announces-pricing-of-secondary-public-offering Massachusetts Healthcare Journal en PressRelease 2026-05-08T02:18:18+00:00 LifeStance Health Group Announces Pricing of Secondary Public Offering https://ml.globenewswire.com/media/08b345f0-a6a4-4217-9255-cce40df2585c/small/lifestance-logo-png.png https://massachusettshealthcarejournal.com/article/911254150-mobia-medical-announces-pricing-of-initial-public-offering Massachusetts Healthcare Journal en PressRelease 2026-05-08T02:10:05+00:00 Mobia Medical Announces Pricing of Initial Public Offering https://ml.globenewswire.com/media/52324ae5-4190-4acb-93b4-aa6f1c996843/small/mobia-medical-logo-color-rgb-400x400-png.png https://massachusettshealthcarejournal.com/article/911094609-xerafy-wins-naumd-innovation-award-for-tex-roll-introducing-print-ready-rain-rfid-tagging-for-uniform-manufacturing Massachusetts Healthcare Journal en PressRelease 2026-05-07T13:59:48+00:00 Xerafy Wins NAUMD Innovation Award for TEX Roll, Introducing Print-Ready RAIN RFID Tagging for Uniform Manufacturing https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24850214-xerafy-printable-tex-roll-rfid-2791x2077.jpeg https://massachusettshealthcarejournal.com/article/911239138-odyssey-therapeutics-announces-pricing-of-upsized-initial-public-offering Massachusetts Healthcare Journal en PressRelease 2026-05-08T00:44:45+00:00 Odyssey Therapeutics Announces Pricing of Upsized Initial Public Offering https://ml.globenewswire.com/media/6da00a97-4976-4d32-9f38-cff9c4f091cf/small/odysseylogo-color-highres-png.png https://massachusettshealthcarejournal.com/article/911239126-innocare-announces-approval-of-a-phase-ii-clinical-trial-of-tyk2-inhibitor-icp-488-for-sj-gren-s-syndrome-in-china Massachusetts Healthcare Journal en PressRelease 2026-05-08T00:30:00+00:00 InnoCare Announces Approval of a Phase II Clinical Trial of TYK2 Inhibitor ICP-488 for Sjögren's Syndrome in China https://ml.globenewswire.com/media/2dc70b00-a0b0-4d85-adef-2717a7067aec/small/innocare-eng-logo-horizontal-png.png https://massachusettshealthcarejournal.com/article/911239075-medipharm-labs-sets-date-to-report-first-quarter-2026-financial-results Massachusetts Healthcare Journal en PressRelease 2026-05-08T00:05:00+00:00 MediPharm Labs Sets Date to Report First Quarter 2026 Financial Results https://ml.globenewswire.com/media/7a534238-60aa-4187-979d-8f4d83fa58c1/small/medipharm-logo-jpg.jpg https://massachusettshealthcarejournal.com/article/910897741-exploring-ai-driven-approaches-to-modernizing-probation-and-parole-in-appa-s-perspectives Massachusetts Healthcare Journal en PressRelease 2026-05-07T12:00:00+00:00 Exploring AI-Driven Approaches to Modernizing Probation and Parole in APPA’s Perspectives https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24842715-q2i-932x270.jpeg https://massachusettshealthcarejournal.com/article/911222901-cue-biopharma-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Massachusetts Healthcare Journal en PressRelease 2026-05-07T23:07:21+00:00 Cue Biopharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/10541379-34cc-4869-a26f-fd99feead42a/small/cue-bio-brand-strategy-graphics-jpg.jpg https://massachusettshealthcarejournal.com/article/911222877-novi-glp-1-weight-loss-claims-evaluated-trusted-semaglutide-tirzepatide-prescription-medication-treatment-options-with-dedicated-doctors Massachusetts Healthcare Journal en PressRelease 2026-05-07T22:50:39+00:00 Novi GLP-1 Weight Loss Claims Evaluated: Trusted Semaglutide & Tirzepatide Prescription Medication Treatment Options with Dedicated Doctors https://zingfast.com/wp-content/uploads/2026/05/Novi-GLP-1-Weight-Loss.jpg https://massachusettshealthcarejournal.com/article/911207186-biosyent-schedules-first-quarter-2026-earnings-release-for-may-14-2026 Massachusetts Healthcare Journal en PressRelease 2026-05-07T22:11:05+00:00 BioSyent Schedules First Quarter 2026 Earnings Release for May 14, 2026 https://ml.globenewswire.com/media/3dded277-7953-4418-be63-7d7a3067811d/small/biosyent-logo-png.png https://massachusettshealthcarejournal.com/article/911207122-vitalhub-reports-first-quarter-2026-results Massachusetts Healthcare Journal en PressRelease 2026-05-07T21:55:00+00:00 VitalHub Reports First Quarter 2026 Results https://ml.globenewswire.com/media/fae8da93-7d5e-4eb4-9121-d724c8555bce/small/greylogo-png.png https://massachusettshealthcarejournal.com/article/911207124-vitalhub-announces-planned-board-succession-with-appointment-of-allan-brett-as-chairman Massachusetts Healthcare Journal en PressRelease 2026-05-07T21:55:00+00:00 VitalHub Announces Planned Board Succession with Appointment of Allan Brett as Chairman https://ml.globenewswire.com/media/fae8da93-7d5e-4eb4-9121-d724c8555bce/small/greylogo-png.png https://massachusettshealthcarejournal.com/article/911207026-extendicare-announces-2026-first-quarter-results Massachusetts Healthcare Journal en PressRelease 2026-05-07T21:24:42+00:00 Extendicare Announces 2026 First Quarter Results https://ml.globenewswire.com/media/6d631964-eede-4e2c-912c-58ab7d1dc35f/small/extendicare-jpg.jpg https://massachusettshealthcarejournal.com/article/911190966-lemaitre-to-present-at-the-bank-of-america-healthcare-conference Massachusetts Healthcare Journal en PressRelease 2026-05-07T21:15:30+00:00 LeMaitre to Present at the Bank of America Healthcare Conference https://ml.globenewswire.com/media/8b8755b7-6f04-4650-9c94-0a2d0654fd49/small/lemaitre-2color-rgb-jpg.jpg https://massachusettshealthcarejournal.com/article/911190225-nova-leap-health-corp-posts-q1-2026-results Massachusetts Healthcare Journal en PressRelease 2026-05-07T21:00:00+00:00 Nova Leap Health Corp. Posts Q1 2026 Results https://ml.globenewswire.com/media/a1093558-bfa0-423d-827b-10c04fa3374d/medium/revenue-in-usd.png https://massachusettshealthcarejournal.com/article/911190801-tarsus-to-participate-in-upcoming-investor-conferences Massachusetts Healthcare Journal en PressRelease 2026-05-07T21:00:00+00:00 Tarsus to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/22d429f7-9b81-4c03-a147-1d9cbc86d1dd/small/tarsus-logo-stacked-color-532x626-png.png https://massachusettshealthcarejournal.com/article/911190911-lifestance-health-group-announces-launch-of-secondary-public-offering Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:51:06+00:00 LifeStance Health Group Announces Launch of Secondary Public Offering https://ml.globenewswire.com/media/08b345f0-a6a4-4217-9255-cce40df2585c/small/lifestance-logo-png.png https://massachusettshealthcarejournal.com/article/911190000-xilio-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:30:00+00:00 Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/7e55cc25-f46f-423c-bf2a-e77ebaf69665/small/xilio-full-clr-logo-cmyk-png.png https://massachusettshealthcarejournal.com/article/911190089-opus-genetics-presents-clinical-and-preclinical-data-at-arvo-2026-demonstrating-continued-pipeline-advancement-in-inherited-retinal-diseases Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:30:00+00:00 Opus Genetics Presents Clinical and Preclinical Data at ARVO 2026 Demonstrating Continued Pipeline Advancement in Inherited Retinal Diseases https://ml.globenewswire.com/media/468baef1-3b2d-4353-a17e-cb41b45ee6ef/small/opus-rgb-r-jpg.jpg https://massachusettshealthcarejournal.com/article/911190241-steris-appoints-pierre-boulud-to-board-of-directors Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:30:00+00:00 STERIS Appoints Pierre Boulud to Board of Directors https://ml.globenewswire.com/media/2c1a9c6d-bc94-4d3f-a47f-0ac0d209f8b6/small/sterishoriz-no-r-rgb-jpg-jpg.jpg https://massachusettshealthcarejournal.com/article/911190332-netramark-announces-change-to-board-of-directors Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:30:00+00:00 NetraMark Announces Change To Board Of Directors https://ml.globenewswire.com/media/d65cf3f8-cf9c-475c-b740-09a659269da4/small/netramark-word-eye-blk-jpg.jpg https://massachusettshealthcarejournal.com/article/911190364-in8bio-reports-first-quarter-2026-financial-results-and-recent-business-highlights Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:30:00+00:00 IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights https://ml.globenewswire.com/media/ab4056e8-16d0-4c44-9ee8-367a47f6ef78/small/in8biologo-jpg.jpg https://massachusettshealthcarejournal.com/article/911190016-cytomx-therapeutics-announces-q1-2026-financial-results-and-provides-business-update Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:15:00+00:00 CytomX Therapeutics Announces Q1 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/c252869d-a4c1-4e56-88e8-d80b85d20c35/small/cytomx-logo-jpg.jpg https://massachusettshealthcarejournal.com/article/911190215-amn-healthcare-announces-first-quarter-2026-results Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:15:00+00:00 AMN Healthcare Announces First Quarter 2026 Results https://ml.globenewswire.com/media/7ac9ce26-e0ee-41e1-94d5-cf8155014873/small/large-amn-logo-wtagline-jpg.jpg https://massachusettshealthcarejournal.com/article/911190232-globus-medical-reports-first-quarter-2026-results Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:15:00+00:00 Globus Medical Reports First Quarter 2026 Results https://ml.globenewswire.com/media/46f81a86-b794-42b0-bf72-63447eb13f53/small/gmlogo-2024-rgb-high-png.png https://massachusettshealthcarejournal.com/article/911190375-cognition-therapeutics-reports-financial-results-for-the-first-quarter-2026-and-provides-business-update Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:15:00+00:00 Cognition Therapeutics Reports Financial Results for the First Quarter 2026 and Provides Business Update https://ml.globenewswire.com/media/a14fd627-7ccb-45e2-95fe-792bbfb83231/small/2020-0227-cognition-logo-for-gnw-png.png https://massachusettshealthcarejournal.com/article/911190538-genelux-corporation-reports-first-quarter-financial-results-and-provides-business-updates Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:15:00+00:00 Genelux Corporation Reports First Quarter Financial Results and Provides Business Updates https://ml.globenewswire.com/media/a4117c65-91cf-479d-9a61-b3edfddde26f/small/genelux-final-logo-notagline-png.png https://massachusettshealthcarejournal.com/article/911190583-restoring-the-biology-of-hair-growth-at-its-root-mblue-labs-launches-next-generation-hair-regeneration-technology Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:12:37+00:00 Restoring the Biology of Hair Growth at its Root: Mblue Labs Launches Next-Generation Hair Regeneration Technology https://ml.globenewswire.com/media/d60c091d-85a3-4cd0-9150-e865a3dfdff9/medium/mblue-labs-launches-next-generation-hair-regeneration-techno.png https://massachusettshealthcarejournal.com/article/911173728-milestone-scientific-schedules-first-quarter-2026-financial-results-and-business-update-conference-call Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:10:00+00:00 Milestone Scientific Schedules First Quarter 2026 Financial Results and Business Update Conference Call https://ml.globenewswire.com/media/408ad3c5-6ad3-41bd-9763-356666216796/small/milestonelogo-rgb-final-jpg.jpg https://massachusettshealthcarejournal.com/article/911174316-omada-health-joins-lilly-employer-connect-expanding-its-access-pathways-for-glp-1-care-as-patients-seek-more-lifestyle-support Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:10:00+00:00 Omada Health Joins Lilly Employer Connect, Expanding Its Access Pathways for GLP-1 Care as Patients Seek More Lifestyle Support https://ml.globenewswire.com/media/f60ce57f-1859-49c3-9423-9562cf46cb64/small/omada-horizontal-color-r-png.png https://massachusettshealthcarejournal.com/article/911173636-nephros-announces-financial-results-for-quarter-ended-march-31-2026 Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:05:00+00:00 Nephros Announces Financial Results for Quarter Ended March 31, 2026 https://ml.globenewswire.com/media/47f2ed6d-a81f-4174-a3eb-0a46a538285e/small/logo-png.png https://massachusettshealthcarejournal.com/article/911173647-madrigal-pharmaceuticals-announces-grants-of-inducement-awards-under-nasdaq-listing-rule-5635-c-4 Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:05:00+00:00 Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/8fec8de1-1a2e-4f6c-a679-fc43002276ba/small/madrigal-logo-jpg.jpg https://massachusettshealthcarejournal.com/article/911173688-tela-bio-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:05:00+00:00 TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/62aad9be-813a-415e-990b-f27442cbec50/small/download-png.png https://massachusettshealthcarejournal.com/article/911173700-jade-biosciences-reports-first-quarter-2026-financial-results-and-provides-corporate-update Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:05:00+00:00 Jade Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/74b5b00e-9a9e-4581-801b-a6e2ddab3aab/small/jade-logo-full-color-rgb-jpg.jpg https://massachusettshealthcarejournal.com/article/911173748-nextcure-provides-business-update-and-reports-first-quarter-2026-financial-results Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:05:00+00:00 NextCure Provides Business Update and Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg https://massachusettshealthcarejournal.com/article/911173756-pyxis-oncology-appoints-nelson-azoulay-as-chief-business-officer Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:05:00+00:00 Pyxis Oncology Appoints Nelson Azoulay as Chief Business Officer https://ml.globenewswire.com/media/d3b77f06-3f52-42af-8f38-e3fda9c8025b/small/pyxis-logo-jpg.jpg https://massachusettshealthcarejournal.com/article/911173778-skinhealth-systems-reports-first-quarter-2026-financial-results Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:05:00+00:00 SkinHealth Systems Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/187132d2-7aef-4a14-8cd2-07829cc11496/small/skinhealthsystems-logo-black-jpg.jpg https://massachusettshealthcarejournal.com/article/911173803-myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:05:00+00:00 Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences https://ml.globenewswire.com/media/5cb679cf-5a10-4b95-8cf7-fd1d0b56721a/small/myriad-s-stacked-png.png https://massachusettshealthcarejournal.com/article/911173806-camp4-reports-first-quarter-2026-financial-results-and-corporate-highlights Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:05:00+00:00 CAMP4 Reports First Quarter 2026 Financial Results and Corporate Highlights https://ml.globenewswire.com/media/72048fc6-0a8d-4ed2-9be8-ec0ee0afd8ba/small/cmp4-21-logo-full-color-jpg.jpg https://massachusettshealthcarejournal.com/article/911173815-immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2026 Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:05:00+00:00 ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026 https://ml.globenewswire.com/media/680330c2-368b-4abc-9429-878b0c9fb1a2/small/immucell-jpg.jpg https://massachusettshealthcarejournal.com/article/911173820-4dmt-reports-first-quarter-2026-financial-results-operational-highlights-and-expected-upcoming-milestones Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:05:00+00:00 4DMT Reports First Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png https://massachusettshealthcarejournal.com/article/911173903-organogenesis-holdings-inc-reports-first-quarter-2026-financial-results Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:05:00+00:00 Organogenesis Holdings Inc. Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/9c2f551f-b7b2-403a-bf43-78f1889401e5/small/organogenesis-jpg.jpg https://massachusettshealthcarejournal.com/article/911174061-zymeworks-provides-corporate-update-and-reports-first-quarter-2026-financial-results Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:05:00+00:00 Zymeworks Provides Corporate Update and Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/de376a45-7a16-49db-8ad4-65ff45472c90/small/zymeworks-logo-color-png.png https://massachusettshealthcarejournal.com/article/911174243-imagenebio-reports-first-quarter-2026-financial-results-and-provides-img-007-program-update Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:05:00+00:00 ImageneBio Reports First Quarter 2026 Financial Results and Provides IMG-007 Program Update https://ml.globenewswire.com/media/ccccc30d-a51c-48d7-9aec-6b542240c611/small/imagene-logo-green-jpg.jpg https://massachusettshealthcarejournal.com/article/911174248-crinetics-pharmaceuticals-reports-first-quarter-2026-financial-results-and-provides-business-update Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:05:00+00:00 Crinetics Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/ff5e7cfa-b9fb-4679-8bf3-6e9d25207b83/small/crinetics-logo-trademark-jpg-1-jpg.jpg https://massachusettshealthcarejournal.com/article/911174271-the-joint-corp-reports-first-quarter-2026-financial-results Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:05:00+00:00 The Joint Corp. Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/ca375acf-3959-4292-8efa-e64eeeca3ed0/small/jynt-792x612px-1-png.png https://massachusettshealthcarejournal.com/article/911174297-atsena-presents-positive-clinical-data-from-its-xlrs-and-lca1-gene-therapy-programs-at-arvo-2026 Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:05:00+00:00 Atsena Presents Positive Clinical Data from Its XLRS and LCA1 Gene Therapy Programs at ARVO 2026 https://ml.globenewswire.com/media/90d0bd84-4404-435c-9875-3473b4cc7172/small/atsena-logo-jpg.jpg https://massachusettshealthcarejournal.com/article/911174303-werewolf-therapeutics-reports-first-quarter-2026-financial-results-and-recent-corporate-updates Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:05:00+00:00 Werewolf Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Updates https://ml.globenewswire.com/media/afa0b662-d7e8-40d2-aad4-824ccfcaddd5/small/wolf-jpg.jpg https://massachusettshealthcarejournal.com/article/911174348-aligos-therapeutics-reports-recent-business-progress-and-first-quarter-2026-financial-results Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:05:00+00:00 Aligos Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results https://ml.globenewswire.com/media/03ffbe89-c47f-4f83-b51f-f13a572e2cd1/small/aligos-png.png https://massachusettshealthcarejournal.com/article/911174508-leonabio-reports-first-quarter-2026-financial-results-and-provides-business-update Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:05:00+00:00 LeonaBio Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/84ac024a-139b-463f-a43f-ed787a66c0fd/small/image1-jpg.jpg https://massachusettshealthcarejournal.com/article/911174548-codexis-reports-first-quarter-2026-financial-results Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:05:00+00:00 Codexis Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/ebbfa755-c2db-4783-aace-43c700ba3369/small/codexis-logo-september-2023-png.png https://massachusettshealthcarejournal.com/article/911174676-profound-medical-reports-strong-first-quarter-2026-financial-results Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:05:00+00:00 Profound Medical Reports Strong First Quarter 2026 Financial Results https://ml.globenewswire.com/media/94d9e057-9de3-430c-9a19-b41ff3e06a1e/small/profound-logo-cmyk-copy-jpg.jpg https://massachusettshealthcarejournal.com/article/911174680-icu-medical-announces-first-quarter-2026-results Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:05:00+00:00 ICU Medical Announces First Quarter 2026 Results https://ml.globenewswire.com/media/44f52bc4-1355-405c-bdac-609254095f19/small/icu-medical-logo-jpg.jpg https://massachusettshealthcarejournal.com/article/911174732-stryker-completes-acquisition-of-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:05:00+00:00 Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio https://ml.globenewswire.com/media/c24fe8bd-9db6-4f42-8a52-06a4e1b673b5/small/stryker-logo2015-jpg.jpg https://massachusettshealthcarejournal.com/article/911174786-vaxart-provides-business-update-and-reports-first-quarter-2026-financial-results Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:05:00+00:00 Vaxart Provides Business Update and Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/aedaf06c-26f8-482c-ac72-39774eab2c35/small/vxrt-logo-jpg.png https://massachusettshealthcarejournal.com/article/911174797-structure-therapeutics-reports-first-quarter-2026-financial-results-and-recent-highlights Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:05:00+00:00 Structure Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights https://ml.globenewswire.com/media/154be1d7-62d7-4688-be20-3b2a10a2628e/small/structure-therapeutics-png.png https://massachusettshealthcarejournal.com/article/911174810-pacbio-announces-first-quarter-2026-financial-results Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:05:00+00:00 PacBio Announces First Quarter 2026 Financial Results https://ml.globenewswire.com/media/f408d681-e68c-4113-a7cd-be24486deefc/small/logo-centered-440x386-png.png https://massachusettshealthcarejournal.com/article/911174817-tomi-environmental-solutions-highlights-steramist-efficacy-in-neutralizing-biohazards-amid-rising-hantavirus-concerns Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:05:00+00:00 TOMI Environmental Solutions Highlights SteraMist Efficacy in Neutralizing Biohazards Amid Rising Hantavirus Concerns https://ml.globenewswire.com/media/f8c7c513-0121-4507-84b7-3680626d9cf3/small/tomi-jpg.jpg https://massachusettshealthcarejournal.com/article/911174975-cytek-biosciences-reports-first-quarter-2026-financial-results Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:05:00+00:00 Cytek Biosciences Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/5a33b17c-e545-48d8-b797-832cf8e4372c/small/cytek-logo-color-jpg.jpg https://massachusettshealthcarejournal.com/article/911174970-omada-health-reports-first-quarter-2026-results Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:03:25+00:00 Omada Health Reports First Quarter 2026 Results https://ml.globenewswire.com/media/f60ce57f-1859-49c3-9423-9562cf46cb64/small/omada-horizontal-color-r-png.png https://massachusettshealthcarejournal.com/article/911173695-outset-medical-reports-first-quarter-results Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:02:00+00:00 Outset Medical Reports First-Quarter Results https://ml.globenewswire.com/media/28778c78-03f1-4b17-9c13-3cc578c924dc/small/outset-id-orangegrey-png.png https://massachusettshealthcarejournal.com/article/911174896-catalyst-pharmaceuticals-cancels-first-quarter-2026-conference-call-and-webcast Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:02:00+00:00 Catalyst Pharmaceuticals Cancels First Quarter 2026 Conference Call and Webcast https://ml.globenewswire.com/media/960a6989-9f9c-4ad2-91cf-be10cebd6655/small/catalyst-pharmaceutical-logo.jpg https://massachusettshealthcarejournal.com/article/911173718-bluejay-diagnostics-provides-first-quarter-2026-corporate-update Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:01:00+00:00 Bluejay Diagnostics Provides First Quarter 2026 Corporate Update https://ml.globenewswire.com/media/d0d4a766-5115-448d-ba8a-d522100949f1/small/bjdx-jpg.jpg https://massachusettshealthcarejournal.com/article/911173810-celldex-reports-first-quarter-financial-results-and-provides-corporate-update Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:01:00+00:00 Celldex Reports First Quarter Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/7a6cc287-087f-4e97-878f-7c1ed1dc5949/small/celldex-logo-rgb-png.png https://massachusettshealthcarejournal.com/article/911173830-tectonic-therapeutic-announces-first-quarter-2026-financial-results-and-recent-business-highlights Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:01:00+00:00 Tectonic Therapeutic Announces First Quarter 2026 Financial Results and Recent Business Highlights https://ml.globenewswire.com/media/7c13d2a1-2971-4ab0-a4b5-608923316546/small/tectonic-logo-full-color-png.png https://massachusettshealthcarejournal.com/article/911173866-xenon-reports-q1-2026-financial-results-and-provides-business-update Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:01:00+00:00 Xenon Reports Q1 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/505b89d3-dfd1-46e8-bc3b-3c9c699ef7ec/small/xenon-logo-tm-full-color-250x80px-png.png https://massachusettshealthcarejournal.com/article/911173899-bridgebio-reports-first-quarter-2026-financial-results-and-corporate-updates Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:01:00+00:00 BridgeBio Reports First Quarter 2026 Financial Results and Corporate Updates https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png https://massachusettshealthcarejournal.com/article/911174023-voyager-reports-first-quarter-2026-financial-and-operating-results Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:01:00+00:00 Voyager Reports First Quarter 2026 Financial and Operating Results https://ml.globenewswire.com/media/f775f55a-83dd-4b38-bf92-bb9b588522bd/small/voyager-logos-square-logo-light-png.png https://massachusettshealthcarejournal.com/article/911174055-senseonics-holdings-inc-reports-first-quarter-2026-financial-results Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:01:00+00:00 Senseonics Holdings, Inc. Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/7f64f449-dd5d-4bd1-9504-82adb3846669/small/logo-png.png https://massachusettshealthcarejournal.com/article/911174167-siga-reports-financial-results-for-three-months-ended-march-31-2026-and-provides-business-update Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:01:00+00:00 SIGA Reports Financial Results for Three Months Ended March 31, 2026 and Provides Business Update https://ml.globenewswire.com/media/93028aa6-8191-4392-a7b1-447b046cd93b/small/siga-logo-blue-png.png https://massachusettshealthcarejournal.com/article/911174322-annexon-reports-first-quarter-2026-financial-results-portfolio-progress-and-key-anticipated-milestones Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:01:00+00:00 Annexon Reports First Quarter 2026 Financial Results, Portfolio Progress and Key Anticipated Milestones https://ml.globenewswire.com/media/fda933a1-e95d-4cae-8894-7b2354118e20/small/annexon-logo-rgb-png.png https://massachusettshealthcarejournal.com/article/911174427-denali-therapeutics-reports-first-quarter-2026-financial-results-and-business-highlights Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:01:00+00:00 Denali Therapeutics Reports First Quarter 2026 Financial Results and Business Highlights https://ml.globenewswire.com/media/898f19a9-f6ef-4d5a-8a4f-27709b81609a/small/denali-green-logo-png.png https://massachusettshealthcarejournal.com/article/911174446-corvus-pharmaceuticals-provides-business-update-and-reports-first-quarter-2026-financial-results Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:01:00+00:00 Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/d05c16d1-5c24-4242-84b5-aea3951ca251/small/corvus-logo-large-jpg.jpg https://massachusettshealthcarejournal.com/article/911174703-progyny-inc-announces-first-quarter-2026-results Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:01:00+00:00 Progyny, Inc. Announces First Quarter 2026 Results https://ml.globenewswire.com/media/1342dacd-99c3-4043-af8a-2fd5e9ea569f/small/progyny-203860-no-tag-png.png https://massachusettshealthcarejournal.com/article/911174783-amneal-reports-first-quarter-2026-financial-results Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:01:00+00:00 Amneal Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/a20d6f40-90af-422f-ab14-47208fdbad2f/small/amneal-rgb-k-png.png https://massachusettshealthcarejournal.com/article/911173712-assembly-biosciences-reports-first-quarter-2026-financial-results-and-recent-highlights Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:00:00+00:00 Assembly Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights https://ml.globenewswire.com/media/33089548-b62b-412d-9343-ae38d8b720c6/small/assemblybio-logo-rgb-png.png https://massachusettshealthcarejournal.com/article/911173960-inmune-bio-inc-announces-first-quarter-2026-results-and-provides-business-update Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:00:00+00:00 INmune Bio Inc. Announces First Quarter 2026 Results and Provides Business Update https://ml.globenewswire.com/media/64035ec0-9fc2-414d-a693-27f1b1e90a31/small/logo-png.png https://massachusettshealthcarejournal.com/article/911174701-adcare-rhode-island-expands-addiction-treatment-access-for-underserved-south-county-by-moving-outpatient-services-to-its-north-kingstown-campus Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:00:00+00:00 AdCare Rhode Island Expands Addiction Treatment Access for Underserved South County by Moving Outpatient Services to its North Kingstown Campus https://ml.globenewswire.com/media/d184b31a-2896-48dd-8479-fc5c8cfc4b98/small/rhode-island-png.png https://massachusettshealthcarejournal.com/article/911174767-acumen-pharmaceuticals-to-participate-in-the-bank-of-america-securities-2026-health-care-conference Massachusetts Healthcare Journal en PressRelease 2026-05-07T20:00:00+00:00 Acumen Pharmaceuticals to Participate in the Bank of America Securities 2026 Health Care Conference https://ml.globenewswire.com/media/53dd23f0-4b5b-4b6b-9dfa-22b5db4c922b/small/picture1-png.png https://massachusettshealthcarejournal.com/article/911174632-dragon-pharma-store-introduces-elevated-safety-protocols-for-peptide-product-distribution Massachusetts Healthcare Journal en PressRelease 2026-05-07T19:25:00+00:00 Dragon Pharma Store Introduces Elevated Safety Protocols for Peptide Product Distribution https://ml.globenewswire.com/media/ecc49d09-485c-4b9b-8f06-2ad672e7cc52/medium/cover-image.jpg https://massachusettshealthcarejournal.com/article/911174609-the-invicta-gala-2026-raises-over-500-000-to-support-life-changing-care-for-veterans-and-first-responders Massachusetts Healthcare Journal en PressRelease 2026-05-07T19:23:19+00:00 The INVICTA Gala 2026 Raises Over $500,000 to Support Life-Changing Care for Veterans and First Responders https://ml.globenewswire.com/media/YmJhN2ZlNmYtYTM3Yy00ZWZhLTllYzktMTgyMWMzNTlkN2VkLTEyMTMzODItMjAyNi0wNS0wNy1lbg==/tiny/Parker-University.png https://massachusettshealthcarejournal.com/article/911174379-leading-u-s-health-benefits-advocacy-group-honors-hii-with-2026-best-employers-award-for-excellence-in-health-care-value Massachusetts Healthcare Journal en PressRelease 2026-05-07T19:15:00+00:00 Leading U.S. Health & Benefits Advocacy Group Honors HII with 2026 Best Employers Award for Excellence in Health Care Value https://ml.globenewswire.com/media/75212ee2-8c56-4924-840e-72fc2462672c/medium/2026-hii-healthcare-award.png https://massachusettshealthcarejournal.com/article/911158315-beacon-therapeutics-announces-positive-12-month-safety-and-efficacy-update-from-phase-2-dawn-trial-of-laru-zova-in-patients-with-x-linked-retinitis Massachusetts Healthcare Journal en PressRelease 2026-05-07T19:00:00+00:00 Beacon Therapeutics Announces Positive 12-Month Safety and Efficacy Update from Phase 2 DAWN Trial of laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP) at ARVO 2026 Annual Meeting https://ml.globenewswire.com/media/020367be-8998-4af7-93ce-7c0c06f88bcd/small/beacon-logo-jpg.jpg https://massachusettshealthcarejournal.com/article/911143404-strengthening-mental-health-and-psychosocial-support-preparedness-in-emergencies Massachusetts Healthcare Journal en PressRelease 2026-05-07T17:31:38+00:00 Strengthening Mental Health and Psychosocial Support Preparedness in Emergencies https://ml.globenewswire.com/media/1b65a0f4-01af-440a-b778-9b5a8e3dc4f2/small/red-cross-png.png https://massachusettshealthcarejournal.com/article/911143408-renforcement-des-services-en-sant-mentale-et-bien-tre-en-pr-paration-aux-situations-d-urgence Massachusetts Healthcare Journal en PressRelease 2026-05-07T17:31:38+00:00 Renforcement des services en santé mentale et bien-être en préparation aux situations d’urgence https://ml.globenewswire.com/media/1b65a0f4-01af-440a-b778-9b5a8e3dc4f2/small/red-cross-png.png https://massachusettshealthcarejournal.com/article/911143395-inviah-launches-beta-in-chicago-the-doctor-comes-to-you Massachusetts Healthcare Journal en PressRelease 2026-05-07T17:20:50+00:00 INVIAH Launches Beta in Chicago: The Doctor Comes to You https://ml.globenewswire.com/media/5faca65e-08a3-4dd0-a67a-62790f6063cd/medium/inivah-co-founders-dr-yevhen-pavelko-and-natallia-panysh.jpeg https://massachusettshealthcarejournal.com/article/911143321-serotonin-centers-highlights-5-day-live-training-program-as-cornerstone-of-franchise-support-and-performance Massachusetts Healthcare Journal en PressRelease 2026-05-07T17:18:00+00:00 Serotonin Centers Highlights 5-Day Live Training Program as Cornerstone of Franchise Support and Performance https://ml.globenewswire.com/media/6d8d9de0-ab7b-477e-b683-4db07437bee6/medium/serotonin-centers-5-day-live-training-session.png https://massachusettshealthcarejournal.com/article/911143280-glucotrack-announces-ide-submission-for-u-s-clinical-study-of-its-novel-implantable-continuous-blood-glucose-monitoring-technology Massachusetts Healthcare Journal en PressRelease 2026-05-07T17:00:00+00:00 Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology https://ml.globenewswire.com/media/3e47bd1b-0cc6-4104-b91d-0ddb9f30f4cc/small/gt-logo-png.png https://massachusettshealthcarejournal.com/article/911143308-the-helios-alliance-applauds-dr-rahul-gupta-s-appointment-to-knoa-foundation-board-of-trustees Massachusetts Healthcare Journal en PressRelease 2026-05-07T16:52:00+00:00 The Helios Alliance Applauds Dr. Rahul Gupta's Appointment to Knoa Foundation Board of Trustees https://pressranger.s3.us-west-1.amazonaws.com/3259151/dr-rahul-gupta-headshot.jpg https://massachusettshealthcarejournal.com/article/911143360-sk-pharmteco-arbeitet-mit-axle-informatics-und-den-national-institutes-of-health-zusammen-um-gentherapieprogramme-bei-seltenen-krankheiten Massachusetts Healthcare Journal en PressRelease 2026-05-07T16:49:14+00:00 SK pharmteco arbeitet mit Axle Informatics und den National Institutes of Health zusammen, um Gentherapieprogramme bei seltenen Krankheiten voranzutreiben https://ml.globenewswire.com/media/038236c2-8cb0-4ff3-8b7e-cbb02b768b37/small/sk-pharmteco-3-png.png https://massachusettshealthcarejournal.com/article/911143363-sk-pharmteco-collabore-avec-axle-informatics-et-les-instituts-nationaux-de-la-sant-afin-de-d-velopper-des-programmes-de-th-rapie-g-nique-pour-les Massachusetts Healthcare Journal en PressRelease 2026-05-07T16:49:14+00:00 SK pharmteco collabore avec Axle Informatics et les Instituts nationaux de la santé afin de développer des programmes de thérapie génique pour les maladies rares https://ml.globenewswire.com/media/038236c2-8cb0-4ff3-8b7e-cbb02b768b37/small/sk-pharmteco-3-png.png https://massachusettshealthcarejournal.com/article/911128648-biorestorative-therapies-reports-expanded-phase-2-blinded-dataset-for-brtx-100-showing-sustained-pain-and-functional-improvements-in-chronic-lumbar Massachusetts Healthcare Journal en PressRelease 2026-05-07T16:00:00+00:00 BioRestorative Therapies Reports Expanded Phase 2 Blinded Dataset for BRTX-100 Showing Sustained Pain and Functional Improvements in Chronic Lumbar Disc Disease https://ml.globenewswire.com/media/a9a09a16-9f91-466d-a0b4-2a7f2fd05ebe/small/logo-png.png https://massachusettshealthcarejournal.com/article/911128669-tomi-environmental-solutions-binary-ionization-technology-approved-in-additional-european-union-countries Massachusetts Healthcare Journal en PressRelease 2026-05-07T16:00:00+00:00 TOMI Environmental Solutions’ Binary Ionization Technology Approved in Additional European Union Countries https://ml.globenewswire.com/media/f8c7c513-0121-4507-84b7-3680626d9cf3/small/tomi-jpg.jpg https://massachusettshealthcarejournal.com/article/911128673-boyce-thompson-institute-names-dr-natalie-hoffmann-inaugural-jane-silverthorne-postdoctoral-fellow Massachusetts Healthcare Journal en PressRelease 2026-05-07T15:44:00+00:00 Boyce Thompson Institute names Dr. Natalie Hoffmann inaugural Jane Silverthorne Postdoctoral Fellow https://pressranger.s3.us-west-1.amazonaws.com/3258963/NHoffmann.jpeg https://massachusettshealthcarejournal.com/article/911114154-sequel-med-tech-s-twiist-recognized-for-diabetes-management-innovation-in-2026-medtech-breakthrough-awards-program Massachusetts Healthcare Journal en PressRelease 2026-05-07T15:05:00+00:00 Sequel Med Tech’s twiist™ Recognized for Diabetes Management Innovation in 2026 MedTech Breakthrough Awards Program https://ml.globenewswire.com/media/27a7520b-9ae6-414c-ae9d-5267dc364671/small/medtech-png.png https://massachusettshealthcarejournal.com/article/911114052-genmab-announces-financial-results-for-the-first-quarter-of-2026 Massachusetts Healthcare Journal en PressRelease 2026-05-07T15:01:57+00:00 Genmab Announces Financial Results for the First Quarter of 2026 https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg https://massachusettshealthcarejournal.com/article/911114147-trinetx-wins-clinical-trial-innovation-award-in-10th-annual-medtech-breakthrough-awards-program Massachusetts Healthcare Journal en PressRelease 2026-05-07T15:00:00+00:00 TriNetX® Wins “Clinical Trial Innovation Award” in 10th Annual MedTech Breakthrough Awards Program https://ml.globenewswire.com/media/27a7520b-9ae6-414c-ae9d-5267dc364671/small/medtech-png.png https://massachusettshealthcarejournal.com/article/911114229-american-kidney-fund-s-sixth-annual-living-donor-protection-report-card-shows-progress-made-highlights-need-for-more-laws-and-regulations-to-protect Massachusetts Healthcare Journal en PressRelease 2026-05-07T14:43:25+00:00 American Kidney Fund's Sixth Annual Living Donor Protection Report Card Shows Progress Made, Highlights Need for More Laws and Regulations to Protect Living Donors https://ml.globenewswire.com/media/NjAzYTViZDgtNWY5MS00NDJiLThmMjYtMDUxODcwNTk4NjViLTExMDkwNTItMjAyNi0wNS0wNy1lbg==/tiny/American-Kidney-Fund.png https://massachusettshealthcarejournal.com/article/911100485-proscia-wins-2026-medtech-breakthrough-award-for-turning-the-moment-of-diagnosis-into-drug-development-insights Massachusetts Healthcare Journal en PressRelease 2026-05-07T14:15:00+00:00 Proscia Wins 2026 MedTech Breakthrough Award for Turning the Moment of Diagnosis into Drug Development Insights https://ml.globenewswire.com/media/4f416775-f097-4445-b40e-323fed394e00/small/proscia-png.png https://massachusettshealthcarejournal.com/article/911100410-chess-health-s-connections-app-named-best-mental-health-app Massachusetts Healthcare Journal en PressRelease 2026-05-07T14:11:00+00:00 CHESS Health’s Connections App Named “Best Mental Health App” https://ml.globenewswire.com/media/YzQ2OTZlNjgtZmI3MS00MmI1LThjNjgtMjc1NmYwMTI2NTNjLTUwMDE0OTE0NS0yMDI2LTA1LTA3LWVu/tiny/CHESS-Health.png https://massachusettshealthcarejournal.com/article/911100479-bruno-vision-care-s-deseyne-wins-2026-medtech-breakthrough-award Massachusetts Healthcare Journal en PressRelease 2026-05-07T14:05:00+00:00 Bruno Vision Care’s Deseyne® Wins 2026 MedTech Breakthrough Award https://ml.globenewswire.com/media/27a7520b-9ae6-414c-ae9d-5267dc364671/small/medtech-png.png https://massachusettshealthcarejournal.com/article/911100704-validic-inform-named-best-iot-healthcare-platform-in-2026-medtech-breakthrough-awards-program Massachusetts Healthcare Journal en PressRelease 2026-05-07T14:02:45+00:00 Validic Inform Named “Best IoT Healthcare Platform” in 2026 MedTech Breakthrough Awards Program https://ml.globenewswire.com/media/5c89ea69-9ba7-4994-a816-9e0fe1f95b46/small/validic-logo-jpg.jpg https://massachusettshealthcarejournal.com/article/911100695-american-urological-association-releases-the-management-of-lower-urinary-tract-symptoms-attributed-to-benign-prostatic-hyperplasia-guideline Massachusetts Healthcare Journal en PressRelease 2026-05-07T14:02:00+00:00 American Urological Association Releases the Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia Guideline https://ml.globenewswire.com/media/M2I5YTU4NTMtMWYwNC00MzMyLWFiOGItMWNhYjdkNjhkMjU0LTEyNzYxOTAtMjAyNi0wNS0wNy1lbg==/tiny/American-Urological-Associatio.png https://massachusettshealthcarejournal.com/article/911100522-timelycare-wins-best-overall-telehealth-solution-in-2026-medtech-breakthrough-awards Massachusetts Healthcare Journal en PressRelease 2026-05-07T14:01:00+00:00 TimelyCare Wins “Best Overall TeleHealth Solution” in 2026 MedTech Breakthrough Awards https://ml.globenewswire.com/media/92461aae-ee69-497b-af0f-1ef840643376/medium/medtech-breakthrough-best-overall-telehealth-solution.jpg https://massachusettshealthcarejournal.com/article/911100434-nsight-health-recognized-for-remote-patient-monitoring-innovation-in-2026-medtech-breakthrough-awards-program Massachusetts Healthcare Journal en PressRelease 2026-05-07T14:00:00+00:00 Nsight Health Recognized for Remote Patient Monitoring Innovation in 2026 MedTech Breakthrough Awards Program https://ml.globenewswire.com/media/27a7520b-9ae6-414c-ae9d-5267dc364671/small/medtech-png.png https://massachusettshealthcarejournal.com/article/911100437-engen-wins-best-core-administrative-processing-system-designation-in-2026-medtech-breakthrough-awards-program Massachusetts Healthcare Journal en PressRelease 2026-05-07T14:00:00+00:00 enGen Wins “Best Core Administrative Processing System” Designation in 2026 MedTech Breakthrough Awards Program https://ml.globenewswire.com/media/27a7520b-9ae6-414c-ae9d-5267dc364671/small/medtech-png.png https://massachusettshealthcarejournal.com/article/911100439-epredia-e1000-dx-digital-pathology-solution-named-best-new-diagnostic-technology-solution-in-2026-medtech-breakthrough-awards-program Massachusetts Healthcare Journal en PressRelease 2026-05-07T14:00:00+00:00 Epredia E1000 Dx™ Digital Pathology Solution Named “Best New Diagnostic Technology Solution” in 2026 MedTech Breakthrough Awards Program https://ml.globenewswire.com/media/27a7520b-9ae6-414c-ae9d-5267dc364671/small/medtech-png.png https://massachusettshealthcarejournal.com/article/911100443-incannex-healthcare-recognized-for-innovative-drug-development-solutions-by-medtech-breakthrough Massachusetts Healthcare Journal en PressRelease 2026-05-07T14:00:00+00:00 Incannex Healthcare Recognized for Innovative Drug Development Solutions by MedTech Breakthrough https://ml.globenewswire.com/media/27a7520b-9ae6-414c-ae9d-5267dc364671/small/medtech-png.png https://massachusettshealthcarejournal.com/article/911100446-evergen-named-best-overall-medtech-company-in-10th-annual-medtech-breakthrough-awards-program Massachusetts Healthcare Journal en PressRelease 2026-05-07T14:00:00+00:00 Evergen Named “Best Overall MedTech Company” in 10th Annual MedTech Breakthrough Awards Program https://ml.globenewswire.com/media/27a7520b-9ae6-414c-ae9d-5267dc364671/small/medtech-png.png https://massachusettshealthcarejournal.com/article/911100468-castlight-health-named-best-healthcare-navigation-solution-in-10th-annual-medtech-breakthrough-awards-program Massachusetts Healthcare Journal en PressRelease 2026-05-07T14:00:00+00:00 Castlight Health Named “Best Healthcare Navigation Solution” in 10th Annual MedTech Breakthrough Awards Program https://ml.globenewswire.com/media/27a7520b-9ae6-414c-ae9d-5267dc364671/small/medtech-png.png https://massachusettshealthcarejournal.com/article/911100473-aarete-s-behavioral-health-intelliscan-wins-2026-medtech-breakthrough-award Massachusetts Healthcare Journal en PressRelease 2026-05-07T14:00:00+00:00 AArete’s Behavioral Health IntelliScan™ Wins 2026 MedTech Breakthrough Award https://ml.globenewswire.com/media/27a7520b-9ae6-414c-ae9d-5267dc364671/small/medtech-png.png https://massachusettshealthcarejournal.com/article/911100482-suvoda-patient-app-earns-best-patient-relationship-management-solution-in-2026-medtech-breakthrough-awards-program Massachusetts Healthcare Journal en PressRelease 2026-05-07T14:00:00+00:00 Suvoda Patient App Earns “Best Patient Relationship Management Solution” In 2026 MedTech Breakthrough Awards Program https://ml.globenewswire.com/media/27a7520b-9ae6-414c-ae9d-5267dc364671/small/medtech-png.png https://massachusettshealthcarejournal.com/article/911100493-a-decade-of-digital-health-innovation-medtech-breakthrough-announces-winners-of-the-10th-annual-awards-program Massachusetts Healthcare Journal en PressRelease 2026-05-07T13:59:00+00:00 A Decade of Digital Health Innovation: MedTech Breakthrough Announces Winners of the 10th Annual Awards Program https://ml.globenewswire.com/media/27a7520b-9ae6-414c-ae9d-5267dc364671/small/medtech-png.png https://massachusettshealthcarejournal.com/article/911100668-standard-dental-labs-inc-closes-acquisition-of-brlit-dental-laboratory-increasing-revenue-base-by-more-than-375 Massachusetts Healthcare Journal en PressRelease 2026-05-07T13:33:30+00:00 Standard Dental Labs Inc. Closes Acquisition of BRLIT Dental Laboratory, Increasing Revenue Base by More Than 375% https://ml.globenewswire.com/media/2369a47c-d78d-419f-acb4-14fafec588aa/small/sdl-logo-2023-02-png.png https://massachusettshealthcarejournal.com/article/911100587-maps-welcomes-liana-gillooly-and-andrew-mo-septimus-to-board-of-directors Massachusetts Healthcare Journal en PressRelease 2026-05-07T13:30:00+00:00 MAPS Welcomes Liana Gillooly and Andrew "Mo" Septimus to Board of Directors https://ml.globenewswire.com/media/024e234c-e545-4328-9da2-a8bbb7ce7ca2/medium/liana-sananda-gillooly.png https://massachusettshealthcarejournal.com/article/911100635-leonabio-enhances-board-of-directors-with-appointments-of-fred-callori-j-d-natalie-holles-and-peter-b-silverman-j-d Massachusetts Healthcare Journal en PressRelease 2026-05-07T13:20:00+00:00 LeonaBio Enhances Board of Directors with Appointments of Fred Callori, J.D., Natalie Holles and Peter B. Silverman, J.D. https://ml.globenewswire.com/media/84ac024a-139b-463f-a43f-ed787a66c0fd/small/image1-jpg.jpg